ML26035A421
Jump to navigation
Jump to search
| ML26035A421 | |
| Person / Time | |
|---|---|
| Site: | SHINE Medical Technologies (CPMIF-001) |
| Issue date: | 02/04/2026 |
| From: | Bartelme J SHINE Technologies |
| To: | Office of Nuclear Reactor Regulation |
| Shared Package | |
| ML26035A418 | List: |
| References | |
| 2026-SMT-0010 | |
| Download: ML26035A421 (0) | |
Text
ENCLOSURE 2 APPLICATION FOR WITHHOLDING OF SHINE TECHNOLOGIES, LLC I, Jeff Bartelme, Senior Director of Regulatory Affairs of SHINE Technologies, LLC.
(SHINE) state that:
- 1. I am the Senior Director of Regulatory Affairs for SHINE and have reviewed the information described in paragraph (2), which is sought to be withheld, and apply for its withholding.
- 2. SHINE is providing information in support of its Application for Order Approving Transfers of Construction Permit and Conforming Administrative Amendments. The proprietary information sought to be withheld in this submittal is that which is appropriately marked is: (1) the estimated costs to complete construction in Table 1, and (2) the amount of funding provided by the U.S. Department of Energy provided.
This information constitutes proprietary commercial and financial information that should be held in confidence by the U.S. Nuclear Regulatory Commission (the NRC) pursuant to the policy reflected in 10 CFR 2.390(a)(4) and 10 CFR 9.17(a)(4) because:
- a. This information is and has been held in confidence by SHINE.
- b. The information is of a type that is held in confidence by SHINE, and there is a rational basis for doing so because the information contains sensitive financial competitive information concerning SHINEs anticipated revenues and operating expenses.
- c. This information is being submitted to the NRC in confidence.
- d. This information has been marked in accordance with 10 CFR 2.390(b)(1).
- e. This information is not available in public sources and could not be readily gathered from other publicly available information.
- f. Although the following statement is no longer required following the Supreme Courts decision in Food Marketing Institute v. Argus Leader Media, the public disclosure of this information would create substantial harm to the competitive position of SHINE by disclosing its internal commercial, financial and proprietary information to other parties whose commercial interests may be adverse to those of SHINE.
- 3. Accordingly, SHINE requests that the designated information in the Application be withheld from public disclosure pursuant to the policy reflected in 10 CFR 2.390(a)(4) and 10 CFR 10.917(a)(4).
- 4. The averments of fact set forth in this affidavit are true and correct to the best of my knowledge, information, and belief.
- 5. I declare under penalty of perjury under the laws of the United States that the foregoing is true and correct.
Executed on this 4th day of February 2026 SHINE Technologies, LLC By: __________________________
Jeff Bartelme Date: _________________________